Compounders Research Compare

enGene Holdings Inc.(ENGN)

Biotechnology · Montreal, QC

$1.83-0.05 (-2.41%)

Delayed quote: Oct 6, 2026, 12:35 PM EDT

About enGene Holdings Inc.

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.

Montreal, QC

82 employees

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ronald H. W. Cooper

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T16:36:53.600Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:36:53.600Z.

Quote observation: 2026-10-06T16:35:08.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-07-31: -0.28
Quote price: 1.825

FMP input reference: fb57f85ed843ad7a76bd5b785e55fde6d0feef1b4d3f081c49812093a2178ef2

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ENGN Earnings Yield Metrics

EARNINGS YIELD

N/A

ENGN Competitors' Earnings Yield

enGene Holdings Inc.

Current

Market Cap

$122.26M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TuHURA Biosciences, Inc.

Market Cap

$121.95M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cibus, Inc.

Market Cap

$121.75M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Seer, Inc.

Market Cap

$121.23M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NRx Pharmaceuticals, Inc.

Market Cap

$125.34M

Earnings Yield

N/A

TTM Avg

0.12%

3Y Avg

0.11%

5Y Avg

0.11%

Entera Bio Ltd.

Market Cap

$126.43M

Earnings Yield

N/A

TTM Avg

60.17%

3Y Avg

53.61%

5Y Avg

53.61%

LENZ Therapeutics, Inc.

Market Cap

$118.52M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Coya Therapeutics, Inc.

Market Cap

$117.03M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Caribou Biosciences, Inc.

Market Cap

$117.03M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Genelux Corporation

Market Cap

$116.14M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
enGene Holdings Inc. (ENGN)	$122.26M	N/A	N/A	N/A	N/A
TuHURA Biosciences, Inc. (HURA)vs ›	$121.95M	N/A	N/A	N/A	N/A
Cibus, Inc. (CBUS)vs ›	$121.75M	N/A	N/A	N/A	N/A
Seer, Inc. (SEER)vs ›	$121.23M	N/A	N/A	N/A	N/A
NRx Pharmaceuticals, Inc. (NRXP)vs ›	$125.34M	N/A	0.12%	0.11%	0.11%
Entera Bio Ltd. (ENTX)vs ›	$126.43M	N/A	60.17%	53.61%	53.61%
LENZ Therapeutics, Inc. (LENZ)vs ›	$118.52M	N/A	N/A	N/A	N/A
Coya Therapeutics, Inc. (COYA)vs ›	$117.03M	N/A	N/A	N/A	N/A
Caribou Biosciences, Inc. (CRBU)vs ›	$117.03M	N/A	N/A	N/A	N/A
Genelux Corporation (GNLX)vs ›	$116.14M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics